LoneStar Heart, Inc. today announced that it received the CE Mark for its Algisyl-LVR hydrogel implant , the company's lead product for the treatment of advanced heart failure . Classified in Europe and in the U.S. as a medical device, Algisyl-LVR is intended to reverse HF progression in people who have an enlarged left ventricle.
http://ift.tt/1rLehQ5
http://ift.tt/1rLehQ5
No comments:
Post a Comment